Senti BiosciencesSNTI
13F holders, Q1 2025 (March 31)15holders
4new positions
4sold out
$3.36avg. 13F price*
At the end of Q1 2025, 15 institutions reported holding Senti Biosciences Inc. (SNTI) in their 13F filings, unchanged from Q4 2024. 4 opened new positions and 4 sold out. The largest holders were NEA Management Company, LLC ($12.7M), Nantahala Capital Management, LLC ($3.0M) and Heights Capital Management, Inc. ($2.5M).
- Company
- Senti Biosciences Inc.
- CUSIP
- 81726A209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $5.5M |
| Exits | 4 | $228K |
All 13F filers, Q4 2024 → Q1 2025: 5,061,234 shares bought and 64,985 shares sold, net +4,996,249 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| NEA Management Company, LLC | 0.98% | Add +753.0% | 3,775,615 | $12.7M |
| Nantahala Capital Management, LLC | 0.25% | New | 888,000 | $3.0M |
| Heights Capital Management, Inc. | 1.29% | New | 750,000 | $2.5M |
| Vanguard Group Inc. | 0.00% | Add +58.1% | 154,136 | $518K |
| UBS Group AG | 0.00% | Add +129.2% | 43,484 | $146K |
| Geode Capital Management, LLC | 0.00% | Add +8.1% | 29,726 | $100K |
| State Street Corp. | 0.00% | No change | 10,010 | $34K |
| Osaic Holdings, Inc. | 0.00% | New | 6,400 | $22K |
| BlackRock, Inc. | 0.00% | No change | 4,004 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +39.3% | 1,425 | $5K |
| SBI Securities Co., Ltd. | 0.00% | Add +0.3% | 338 | $1K |
| Morgan Stanley | 0.00% | No change | 160 | $538 |
| Bank of America Corp. | 0.00% | Add +5.0% | 126 | $423 |
| Barclays PLC | 0.00% | No change | 30 | $101 |
| JPMorgan Chase & Co. | 0.00% | New | 9 | $30 |
"% of holder's portfolio" is SNTI's weight in each manager's 13F, not the share of Senti Biosciences Inc. the manager owns.